ICD-11 Criteria for Opioid Use Disorder
ICD-11 condenses the six diagnostic criteria from ICD-10 into three paired criteria for substance dependence (including opioid dependence), requiring two of the three pairs to be met for diagnosis, with only one symptom within each pair needing to be present.
Diagnostic Framework
ICD-11 maintains the distinction between harmful patterns of substance use and substance dependence as separate diagnostic categories 1, 2, 3. This differs fundamentally from DSM-5, which merged abuse and dependence into a single "substance use disorder" spectrum.
The Three Paired Criteria
The six ICD-10 criteria have been restructured into three pairs 1, 2:
- Impaired control over substance use (combining tolerance and withdrawal-related criteria)
- Substance use becoming a priority (combining compulsion and time spent obtaining/using)
- Continued use despite harm (notably reworded from ICD-10's "persistent substance use despite clear evidence of overtly harmful consequences" to the broader "substance use often continues despite the occurrence of problems") 1, 2
To diagnose opioid dependence in ICD-11, at least two of these three paired criteria must be fulfilled, with only one symptom from within each pair needing to be present 1.
Critical Concerns with ICD-11 Criteria
Reduced Specificity
The condensation from six to three criteria raises significant concerns about diagnostic specificity 1, 2. Because only one symptom within each pair must be present, the threshold for diagnosis is effectively lowered compared to ICD-10. Early multinational studies demonstrate approximately 10% higher rates of alcohol dependence diagnosis using ICD-11 compared to ICD-10 1.
Problematic Criterion Rewording
The change from "clear evidence of overtly harmful consequences" to "substance use often continues despite the occurrence of problems" is particularly concerning 1, 2. This broader language may pathologize social and legal problems rather than true medical dependence—for instance, the criterion could be met simply because opioid use is illegal in a given jurisdiction, even without actual physical or psychological harm 1, 2.
Risk of False Positives
The reduced specificity increases the risk of false-positive diagnoses of opioid dependence 1. This is clinically significant because misdiagnosis can lead to inappropriate treatment interventions, stigmatization, and social consequences for patients who may have problematic use patterns but do not meet the threshold for true physiological dependence.
Comparison with Other Systems
ICD-11 vs. DSM-5
While DSM-5 uses 11 criteria with severity gradations (2-3 criteria = mild, 4-5 = moderate, ≥6 = severe) 4, ICD-11 retains dependence as the "master diagnosis" 3. Agreement between ICD-11 and DSM-5 is only fair to moderate, whereas ICD-11 shows excellent agreement (κ>0.90) with ICD-10 and DSM-IV dependence criteria 5.
Model Fit
Confirmatory factor analysis demonstrates that ICD-11 dependence criteria show the best model fit among classification systems, while DSM-5 shows the worst 5. This suggests ICD-11's more parsimonious approach may better capture the underlying construct of dependence.
Clinical Application
For opioid use disorder specifically:
- Assess for impaired control: Evidence of tolerance, withdrawal symptoms, or inability to cut down despite desire
- Evaluate priority of use: Time spent obtaining opioids, neglect of other activities, compulsive use patterns
- Document harm despite continued use: Physical health consequences, psychological problems, social/occupational impairment, or legal issues related to continued opioid use
Two of these three domains must be present, with at least one clear manifestation in each endorsed domain.
Common Pitfalls
- Avoid over-reliance on legal status alone for the "continued use despite problems" criterion—seek evidence of actual medical, psychological, or functional harm 1, 2
- Do not confuse physiological dependence (expected with chronic opioid therapy) with opioid use disorder—the disorder requires the behavioral and control elements, not just tolerance and withdrawal 6, 7
- Be cautious with the lowered threshold—consider clinical context and severity before labeling patients, particularly those on prescribed opioid therapy for chronic pain 5